CD274 and neoplasm: ICIs further reinvigorate exhausted T cells by blocking inhibitory PD-1/PD-L1 interactions, thereby restoring cytotoxic T lymphocyte (CTL) activity and sustaining anti-tumor immunity within the TME (50).